Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2017Doran JA, Sajjad W, Schneider MD, et al.

Study designRandomized controlled trial

SubjectHuman

Record checks

Study design: Randomized controlled trial
Subject: Human
Publication year: 2017
Source: doi.org
Abstract display: Not reproduced here
Publication status: Retracted
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Flagged

How to read this record →

Publication-status notice

Publication status: Retracted

Europe PMC relationship metadata: retracted_by.

View status evidence →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Administration, OralAgedAminophyllineCaffeineCardiotonic AgentsCausalityDrug InteractionsDrug-Related Side Effects and Adverse ReactionsExercise TestFemaleHumansIncidenceInjections, IntravenousMaleMiddle AgedMyocardial Perfusion ImagingNew YorkPurinesPyrazolesSurvival RateTomography, Emission-Computed, Single-PhotonTreatment OutcomeVasodilator Agents

DOI 10.1007/s12350-016-0452-0

PMID 27025843

View source →